Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Carboprost tromethamine
Drug ID BADD_D00366
Description A nonsteroidal abortifacient agent that is effective in both the first and second trimesters of pregnancy.
Indications and Usage For aborting pregnancy between the 13th and 20th weeks of gestation as calculated from the first day of the last normal menstrual period and in the following conditions related to second trimester abortion: 1. Failure of expulsion of the fetus during the course of treatment by another method; 2. Premature rupture of membranes in intrauterine methods with loss of drug and insufficient or absent uterine activity; 3. Requirement of a repeat intrauterine instillation of drug for expulsion of the fetus; 4. Inadvertent or spontaneous rupture of membranes in the presence of a previable fetus and absence of adequate activity for expulsion. Also for the treatment of postpartum hemorrhage due to uterine atony which has not responded to conventional methods of management.
Marketing Status approved
ATC Code Not Available
DrugBank ID DB00429
KEGG ID D00682
MeSH ID C062843
PubChem ID 5281074
TTD Drug ID D07PCI
NDC Product Code 68245-0016; 43598-917; 65219-579; 55150-459; 62227-023; 82231-103; 71839-137; 70512-859; 81298-5010; 65145-132; 54893-0023; 0009-0856; 69784-240; 70121-1680; 62332-777; 43598-698; 43598-919
UNII U4526F86FJ
Synonyms carboprost tromethamine | carboprost trometamol | 15-methylprostaglandin F2alpha-tromethamine | Hemabate | Prostin M-15
Chemical Information
Molecular Formula C25H47NO8
CAS Registry Number 58551-69-2
SMILES CCCCCC(C)(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O.C(C(CO)(CO)N)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Retching07.01.07.002--Not Available
Septic shock24.06.02.011; 11.01.11.004--Not Available
Sleep disorder19.02.04.001--Not Available
Somnolence19.02.05.003; 17.02.04.006--
Swelling08.01.03.0150.000041%Not Available
Syncope02.11.04.015; 24.06.02.012; 17.02.04.008--
Tachycardia02.03.02.007--Not Available
Tachypnoea22.02.01.0140.000041%Not Available
Thirst08.01.09.021; 14.03.02.007--Not Available
Throat tightness22.12.03.031; 19.01.02.005--Not Available
Thyrotoxic crisis19.07.03.006; 14.11.01.016; 06.09.04.004; 05.02.02.004--Not Available
Tinnitus04.04.01.002; 17.04.07.004--
Torticollis17.01.03.003; 15.05.04.003--Not Available
Tremor17.01.06.0020.000041%
Upper respiratory tract infection22.07.03.011; 11.01.13.009--
Urinary tract infection20.08.02.001; 11.01.14.004--
Uterine perforation21.07.01.010; 12.02.14.002--
Uterine rupture21.07.01.009; 18.02.02.001; 12.01.15.001--Not Available
Vertigo04.04.01.003; 17.02.12.002--
Vision blurred17.17.01.010; 06.02.06.007--
Visual field defect06.02.07.003; 17.17.01.0010.000041%Not Available
Vomiting07.01.07.0030.000305%
Wheezing22.03.01.009--
Uterine cyst21.07.02.007; 16.04.02.003--Not Available
Injection site swelling12.07.03.018; 08.02.03.0170.000207%Not Available
Hot flush08.01.03.027; 24.03.01.005; 21.02.02.001--
Perforation08.01.03.058--Not Available
Anal incontinence17.05.01.021; 07.01.06.0290.000102%
The 3th Page    First    Pre   3    Total 3 Pages